Navigation Links
Study Analyzed SYMBICORT(R) in Children with Persistent Asthma
Date:5/20/2008

WILMINGTON, Del., May 20 /PRNewswire-FirstCall/ -- A new 12-week study(2) examined safety and efficacy measures of the maintenance combination asthma therapy, SYMBICORT(R) (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol(2) in treating mild to moderate persistent asthma in children ages 6 to 15 years old(2) who were previously treated with an inhaled corticosteroid (ICS).(2) Of note, the study included efficacy assessments of nighttime symptoms, nighttime rescue medication use and rescue medication-free days in patients taking SYMBICORT compared to those taking formoterol dry powder inhaler (DPI) or budesonide pressurized metered-dose inhaler (pMDI). Results were presented today at the International Conference of the American Thoracic Society held in Toronto, Canada, May 16-21, 2008.

"Children with asthma, who are not adequately controlled by ICS therapy, may have their sleep affected by asthma symptoms,"(6) said Kathy Lampl, MD, Director, Clinical Research, AstraZeneca. "Combination therapy with inhaled ICS and LABA is one of the recommended regimens for children who have moderate to severe persistent asthma or are not controlled with ICS therapy alone, according to the NIH Guidelines."(7)

AstraZeneca (NYSE: AZN) anticipates filing a supplemental new drug application with the Food and Drug Administration for the pediatric indication of SYMBICORT in the first half of 2008.

About the Study (Abstracts #K66 and K67)

The safety profile and efficacy measures of SYMBICORT were assessed during a 12-week randomized, double-blind, active-controlled study that evaluated 411 children ages 6 to 15 years old with mild to moderate persistent asthma(1,2) previously treated with ICS therapy.(1,2) After a two-week p
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
3. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
4. Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
5. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
6. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
7. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
8. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
9. Amikacin Inhale Shows Promising Results in Phase II Study
10. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
11. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... August 31, 2015 A ... global cardiovascular monitoring and diagnostic devices market stood ... to reach a value of approximately US$7.0 billion ... between 2013 and 2019. The title of the ... (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, ...
(Date:8/31/2015)... 2015  Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), ... commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad ... in four investor conferences in September. ... & Company, LLC Emerging Growth Conference in ... Luci , President & Chief Executive Officer, will present ...
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with ... care management solutions powered by Qualcomm Life,s 2net™ ... to enable continuous care, informed interventions and better ... at Qualcomm Life,s annual Connect 2015 ...
Breaking Medicine Technology:Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... Continuing Progress on Clinical and Preclinical Programs, ... KAL; FWB: CA4), a developer of new drug ... is pleased to provide an,update covering its strategic ... 2007. "Callisto has made substantial progress with ...
... ... with Results due in Q1 ... 2008, ... PPGNY) today,announced the successful completion of a Phase 1b transdermal insulin,trial. The positive ...
Cached Medicine Technology:Callisto Reports on Second-Quarter 2007 Milestones 2Callisto Reports on Second-Quarter 2007 Milestones 3Callisto Reports on Second-Quarter 2007 Milestones 4Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results 2Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results 3
(Date:8/31/2015)... ... August 31, 2015 , ... ... psychology professor Luciana Lagana (aka Dr. Luciana) received a total of three ... Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) and ... and a patent pending ICD-10 solution - ezCAC is an enterprise-level coding solution ...
(Date:8/31/2015)... New York (PRWEB) , ... August 31, 2015 , ... ... autumn, when play-offs and the World Series will dominate the sports world. Fans desire ... and eventually advance to the final series. For children, especially those who are too ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... On Saturday, ... A Mission” at the Adams County Fairgrounds in Mendon, IL. The purpose behind this ... districts of Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... In ... studies, Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 ... sound amplifiers as a way of coping with a variety of home healthcare challenges, ...
Breaking Medicine News(10 mins):Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... Group Will Work to Prevent Sudden Cardiac Arrest Through ... Sudden Cardiac Arrest,Association (SCAA) announced today that it has ... of local organizations to help carry out its,mission of ... chapter is led by Elliot Fisch of Boca Raton, ...
... to Prevent Sudden Cardiac Arrest Through Public,Education and Advocacy, ... Spring, WASHINGTON, Jan. 8 The Sudden Cardiac ... first 13 local,chapter and affiliate organizations, as it builds ... mission of preventing sudden cardiac,arrest., The local chapters ...
... Over-The-Air Transmission From Special CES Station, LAS ... Harris,Corporation and Towson University today announced a new ... of millions of hearing and visually,impaired people around ... the Consumer Electronics Show in Las Vegas,the three ...
... The Department of Labor,s,Occupational Safety and Health Administration ... review of its methylene chloride (MC),Standard (29 CFR ... July 10, 2007, Federal Register (72 FR 37501 ... 1997 to protect employees from occupational,exposure to MC. ...
... Metabolism, a publication of Cell Press, provides new evidence explaining ... muscles up in response to exercise. These findings could lead ... occurs in diseases such as cancer and AIDS as well ... , The researchers showed that a transient and local rise ...
... risk, experts say , , TUESDAY, Jan. 8 (HealthDay News) -- ... risk of having a heart attack, a new study reports. ... of heart problems, this is the first time that chronic ... "There is an independent contribution of anxiety that can predict ...
Cached Medicine News:Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 2Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 3Health News:Sudden Cardiac Arrest Association Launches Its First Thirteen Local Chapters/Affiliates 2Health News:Sudden Cardiac Arrest Association Launches Its First Thirteen Local Chapters/Affiliates 3Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 2Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 3Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 4Health News:NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired 5Health News:OSHA Extends Comment Period for Lookback Review of Methylene Chloride Standard 2Health News:New insight into factors that drive muscle-building stem cells 2Health News:Anxiety Raises Heart Attack Risk 2Health News:Anxiety Raises Heart Attack Risk 3
Direct assays, no sample extraction, hydrolysis or other pretreatment required. Highly specific antiserum, minimal cross-reactivity with estrone, estradiol and other estrogen metabolites....
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
... Helmer presents the ... with innovative solutions for ... more sophisticated features than ... Bank Refrigerators are at ...
... the precise requirements of blood banking ... Bank Equipment meets American Association of ... Cross (ANRC) and U.S. Food & ... freezers, and platelet incubators feature alarm ...
Medicine Products: